Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conmed Corp (NASDAQ:CNMD)

48.60
Delayed Data
As of Jul 01
 +0.87 / +1.82%
Today’s Change
35.51
Today|||52-Week Range
60.66
+10.33%
Year-to-Date
CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Jun 30 / Zacks.com - Paid Partner Content
DENTSPLY Sirona (XRAY): Q1 Strong, Expansion on Track
Jun 20 / Zacks.com - Paid Partner Content
DENTSPLY Sirona Set to Acquire MIS Implants for $375M
Jun 28 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close47.73
Today’s open47.87
Day’s range47.56 - 48.62
Volume159,498
Average volume (3 months)193,472
Market cap$1.3B
Dividend yield1.65%
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-6.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.82%
Revenue growth (last year)-4.28%
P/E ratio61.7
Price/Sales1.73
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.21+0.89%
XLRNAcceleron Pharma Inc+1.29+3.80%
PCRXPacira Pharmaceutica...-0.25-0.74%
CYNOCynosure Inc+0.34+0.71%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$708.8M
Annual profit (last year)$30.5M
Net profit margin4.30%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Curt R. Hartman
Executive VP-Operations &
Business Systems
Mark D. Snyder
Corporate headquarters
Utica, New York

Forecasts

Partner Offers

Search for Jobs